Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$36,996,096
in 12 filings, $37.0M under 10b5-1 plans

Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-25 Telman Deborah H EVP, Corporate Affairs & GC Option exercise · Restricted Stock Unit −515 39,568
2024-04-01 Parsey Merdad Chief Medical Officer Sale 10b5-1 −2,000 $72.96 $146K 96,304
2024-03-28 Lofton Kevin E Director Grant or award · Phantom Stock +33.89 3,258.14
2024-03-10 Telman Deborah H EVP, Corporate Affairs & GC Option exercise +2,555 14,603
2024-03-10 Telman Deborah H EVP, Corporate Affairs & GC Shares withheld for taxes −846 $75.12 $64K 13,757
2024-03-10 Telman Deborah H EVP, Corporate Affairs & GC Option exercise · Restricted Stock Unit −2,555 29,268
2024-03-10 Telman Deborah H EVP, Corporate Affairs & GC Grant or award · Non-qualified Stock Option (Right to Buy) +54,980 54,980
2024-03-10 Telman Deborah H EVP, Corporate Affairs & GC Grant or award · Restricted Stock Unit +10,815 40,083
2024-03-10 Patterson Sandra SVP, Controllership Option exercise +748 31,488
2024-03-10 Patterson Sandra SVP, Controllership Option exercise +1,934 33,422
2024-03-10 Patterson Sandra SVP, Controllership Shares withheld for taxes −790 $75.12 $59K 32,632
2024-03-10 Patterson Sandra SVP, Controllership Option exercise · Restricted Stock Unit −748 15,772
2024-03-10 Patterson Sandra SVP, Controllership Option exercise · Restricted Stock Unit −1,934 13,838
2024-03-10 Patterson Sandra SVP, Controllership Grant or award · Non-qualified Stock Option (Right to Buy) +13,660 13,660
2024-03-10 Patterson Sandra SVP, Controllership Grant or award · Restricted Stock Unit +4,825 18,663
2024-03-10 Parsey Merdad Chief Medical Officer Option exercise +3,455 96,161
2024-03-10 Parsey Merdad Chief Medical Officer Option exercise +6,946 103,107
2024-03-10 Parsey Merdad Chief Medical Officer Shares withheld for taxes −4,803 $75.12 $361K 98,304
2024-03-10 Parsey Merdad Chief Medical Officer Option exercise · Restricted Stock Unit −3,455 37,520
2024-03-10 Parsey Merdad Chief Medical Officer Option exercise · Restricted Stock Unit −6,946 30,574

Page 28 of 30 · 590 trades